vialroom

#semaglutide 2025-12-20

Saturday37 messages7 participantstimes are UTC
Highlights from this day
  • ghk_gia — update on the earlier thing lost about 11kg on the low doses before i even got to 1, which surprised me 18:24
  • ghk_gia — i dont think the plateau is a dose problem most of the time, but i cant prove that 18:27
  • VialBot — Verification log updated: GL Biochem — evidence added, status unchanged. 18:35
  • gip_glp_gil — if youre comparing brand to compounded, dose accuracy in the vial is the variable, not the molecule, still working it out 19:56
  • secretagogue_sy — went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step 20:02
GG

going slow cost me nothing except time and saved me two bad weeks, thats my whole contribution

GG

the plateau hit me at 19 weeks and moved again about a month later without a dose change

held there too

GG

while im here is the plateau usually appetite coming back or just the scale stopping

was SURMOUNT-1 the one that ran to 68 weeks or am i mixing them up

did anyone hold at 12 longer than four weeks before going up

anyone compared their 10 vial dosing against the pen increments

give it four weeks

went too fast once

right so the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing

steady state is the bit people skip, judging a new dose after eight days tells you almost nothing, ymmv

👀3👍2

did anybody find a difference between QYB and pharmacy at the same 2.4

GG

update on the earlier thing lost about 11kg on the low doses before i even got to 1, which surprised me

Cited study
Once-Weekly Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes (STEP 2)
The Lancet · 2021
The type 2 diabetes population, where the weight response is generally smaller.

i dont think the plateau is a dose problem most of the time, but i cant prove that

📈11👍6

does the licensed ceiling for weight differ from the diabetes one

*PeptideMeter not the other one

VB

Verification log updated: GL Biochem — evidence added, status unchanged.

3
BB

the appetite effect faded for me around 24 months and going up fixed it for a while

GG

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial, ymmv

SS

coming back to this is the plateau at 13 weeks normal or am i doing something wrong

my PeptideMeter report on the JEEP vial came back 99.2 against a certificate saying 96.8, someone check my working

does anyone actually run a five week step instead of four

📈3🧊2🔥1
LM

coming back to this anyone gone from 15 straight to 1.7 or is that too big a jump

GG

is there a reason to hold at 1.7 rather than going to 2.4

🔥5
SS

unrelated but restarted after 22 months off at a low dose and the nausea arrived exactly like the first time

GG

if youre comparing brand to compounded, dose accuracy in the vial is the variable, not the molecule, still working it out

🧊1418🧪7

changed my mind on the four week rule, i think it depends entirely on how the current dose feels

went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance
🧪12💀1👀18